Highlights Kissei Pharmaceutical Co., Ltd.

Equities

4547

JP3240600001

Market Closed - Japan Exchange Other stock markets 07:00:00 13/05/2024 BST			5-day change	1st Jan Change
3,130 ^JPY	-1.73%		-14.25%	+1.29%

05-08	Japanese Shares Swing to Red Amid Profit-Taking, US Rate Cut Uncertainty	MT
03-20	Kissei Pharmaceutical Completes 6 Billion Yen Buyback Program	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kissei Pharmaceutical's Attributable Profit Jumps 6% in Fiscal 2023; Shares Tumble 11%	05-08	MT
Final dividend	03-27	FA
Kissei Pharmaceutical Completes 6 Billion Yen Buyback Program	03-20	MT
Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023.	03-19	CI
Kissei Pharmaceutical Co., Ltd.'s Equity Buyback announced on May 8, 2023, has closed with 1,909,900 shares, representing 4.18% for ¥5,999.99 million.	03-17	CI
Kissei Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Year Ending March 2024	01-30	CI
Kissei Pharmaceutical Repurchases 251 Million Yen Worth of Shares in December 2023	01-04	MT
Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023.	01-04	CI
Kissei Pharmaceutical Co., Ltd. and Maruishi Pharmaceutical Co., Ltd. Announces KORSUVA®? IV Injection Syringe for Dialysis 17.5ug, 25.0ug to Launch in Japan for Treatment of Pruritus in Patients Undergoing Hemodialysis	12-12	CI
Japanese Shares Close Lower on Tuesday After Key Economic Data	11-07	MT
Kissei Pharmaceutical's Fiscal H1 Attributable Profit Surges as Net Sales Gains	11-07	MT
Kissei Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	11-06	CI
Kissei Pharmaceutical Co., Ltd. Announces Second Quarter-End Dividend for the Year Ending March 31, 2024, Payable on December 4, 2023 and Provided Dividend Guidance for the Year Ending March 31, 2024	11-06	CI
Kissei Pharmaceutical Co., Ltd. Revises Consolidated Earnings Guidance for the First Half Ending September 30, 2023	27/10/23	CI
Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023.	02/10/23	CI
Ex-dividend day for interim dividend	27/09/23	FA
Kissei Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal Year Ending March 31, 2024	31/07/23	CI
Kissei Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2024	31/07/23	CI
Kissei Pharmaceutical Co., Ltd. Announces Withdrawal of Application for Marketing Approval for Rovatirelin for the Treatment of Spinocerebellar Degeneration in Japan	19/07/23	CI
Kissei Pharmaceutical Co., Ltd. Introduces Iktos AI Drug Discovery System	03/07/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Kissei Pharmaceutical Co., Ltd.

Equities

4547

JP3240600001

Highlights

Filters